Takeda bets $500M on a freshly unstealthed biotech

Japanese pharma giant Takeda is promising as much as $500 million to a previously under-wraps biotech company with some early-stage drugs that could provide a more tolerable alternative to steroid treatments.

Source: www.fiercebiotech.com

---